Caveats regarding a family with PD and LRRK2 mutations
Objective: To describe and discuss genetic considerations regarding a kindred with PD cases with similar clinical characteristics, some with identified mutations in the LRRK2 gene…Words Spoken Daily: A Novel Measure of Cognition
Objective: To assess the average number of words spoken per day by individuals with Parkinson’s disease (PD), mild cognitive impairment (MCI), and control participants. Background:…Impact of vitamin supplements intake on non-motor fluctuations measured by (NoMoFA) in people living with Parkinson’s disease.
Objective: To determine the impact of vitamins supplements on non-motor fluctuations in people living with Parkinson's disease (PEP). Background: Parkinson's disease (PD) is a neurodegenerative…Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease
Objective: We investigated prevalence of Cardiovascular drugs and Oral anticoagulants (OAC) use among community-dwelling persons with and without Parkinson's disease (PD) in relation to PD…Age-associated changes in the striatal proteins in aging Asian-Indians
Objective: To examine the age-related changes in tyrosine hydroxylase (TH), vesicular monoamine transporter2 (VMAT2), post-synaptic density protein-95 (PSD-95) and dopamine receptors (D1R, D2R) expression in the…Clinical Prediction of GBA Carrier Status in Parkinson’s Disease
Objective: To design a model for prediction of GBA carrier status based on clinical and demographic features in a cohort of PD patients. Background: Given…using latent class mixed modelling to profile Parkinson’s disease patients at risk of cognitive decline
Objective: To determine the clinical profile of cognitive subtypes in Parkinson's disease (PD) based on their rate of change in global cognitive ability over time.…Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease
Objective: The aim of this study is to map patients’ reports of functional limitations and impacts of Parkinson’s disease (PD) to motor signs captured with…Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease
Objective: The aim of this study was to explore the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on…Dysconnectivity of the Parafascicular Nucleus in Parkinson’s Disease
Objective: The present study aimed to investigate the functional alterations of the parafascicular nucleus (Pf) projections in Parkinson’s disease (PD) patients. Background: Recent animal model…
- « Previous Page
- 1
- …
- 258
- 259
- 260
- 261
- 262
- …
- 436
- Next Page »